At a glance

ClinicalIndex Comparison Record

Phase 3Completed

Drug / intervention

estrogen replacement therapy +3 moredrug

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000549

NCT00000549Phase 3Completed

Compare CT.gov

Estrogen Replacement and Atherosclerosis (ERA) in Older Women

National Heart, Lung, and Blood Institute (NHLBI)·interventional·Posted Oct 28, 1999·Updated Mar 16, 2016

In Brief

A Phase 3 clinical trial evaluating estrogen replacement therapy, hormone replacement therapy, and 2 other interventions for Cardiovascular Diseases and 5 related conditions. Completed.

Detailed Summary

To determine if estrogen replacement therapy, with or without low dose progesterone, slows progression or induces regression of coronary atherosclerosis in postmenopausal women.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsCardiovascular Diseases, Coronary Arteriosclerosis, Coronary Disease, Heart Diseases, Myocardial Ischemia, Postmenopause

Countries--

Collaborators--

Timeline

Phase 3CompletedFinished

1994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027

Enrollment StartAug 1994

First PostedOct 1999

Study CompletionJul 2000

TodayJul 2026

First PostedOct 28, 1999

Enrollment StartAug 1, 1994

Study CompletionJul 1, 2000

TodayJul 2, 2026

Posted 26.7 years ago

Interventions

estrogen replacement therapydrug

hormone replacement therapydrug

estrogensdrug

progestinsdrug